30
4
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T23897 | CLK1/2-IN-3 | CLK1/2 inhibitor 3,CLK1/2-inhibitor-3,CLK1/2 IN 3,CLK1/2IN3 | CDK |
CLK1/2-IN-3 (Cpd-3) is a potent and selective CLK1 and CLK2 inhibitor with antiproliferative activity and inhibits the activities of CLK1, CLK2, SRPK1, SRPK2, and SRPK3.CLK1/2-IN-3 induces nuclear speckle enlargement, wh... | |||
T72039 | CLK1-IN-3 | DYRK , CDK , Autophagy | |
Clk1-in-3 is a + selective and highly potent sexual Clk1 inhibitor with an IC50 of 5 nM and 300 pairs higher affinity than Dyrk1A. CLK1-IN-3 also showed highly effective inhibition of Clk2 and Clk4, with IC50 values of 4... | |||
T23896 | CLK1/2-IN-1 | CLK1/2 inhibitor 1,CLK1/2IN1,CLK1/2-inhibitor-1 | |
CLK1/2-IN-1 is a CLK1 and CLK2 inhibitor and it also inhibits SRPK1 and SRPK2. | |||
T10836 | CLK1-IN-1 | CDK | |
CLK1-IN-1 is a potent and selective inhibitor of the Cdc2-like kinase 1 (CLK1; IC50: 2 nM). | |||
T24439 | MDK6204 | CLK1/2 IN 2,CLK1/2IN2,CLK1/2-inhibitor-2,CLK1/2-IN-2,CLK1/2 inhibitor 2 | |
MDK6204 is a selective inhibitor of CLK1 and CLK2. | |||
T73321 | CLK1-IN-2 | ||
CLK1-IN-2, a metabolically stable Clk1 inhibitor, exhibits selective activity for Clk1 with an IC50 value of 1.7 nM. It is applicable in researching tumor, Duchenne's muscular dystrophy, and viral infections including HI... | |||
T61543 | CLK1/4-IN-1 | ||
CLK1/4-IN-1 (compound 31) is a highly potent and selective inhibitor of Clk1 and Clk4, with IC50 values of 9.7 nM and 6.6 nM, respectively. It effectively inhibits the growth of T24 cancer cells, with a GI50 value of 1.1... | |||
T74805 | T74805 | ||
CLK1-IN-3 (compound 10ad) is a potent and selective Clk1 inhibitor, with an IC 50 of 5 nM and over 300-fold selectivity for Dyrk1A . CLK1-IN-3 also shows a relatively potent inhibition against Clk2 and Clk4 , with IC 50 ... | |||
T8418 | DCLK1-IN-1 | Others | |
DCLK1-IN-1 is a selective and in vivo-compatible chemical probe of the DCLK1 kinase domain . | |||
T79421 | DCLK1-IN-2 | ||
DCLK1-IN-2 (Compound I-5) is a potent inhibitor of DCLK1, exhibiting an IC50 of 171.3 nM, and demonstrates significant antiproliferative effects on SW1990 cell lines with an IC50 of 0.6 μM, as well as in vivo antitumor p... | |||
T14980 | CLK-IN-T3 | DYRK , CDK | |
CLK-IN-T3 is an inhibitor of CLK1, CLK2, and CLK3 with IC50s of 0.67, 15, and 110 nM. CLK-IN-T3 exhibits anti-cancer activity. | |||
T8801 | SRI-29329 | CDK | |
SRI-29329 is a potent, specific inhibitor of CDC-like kinase (with IC50 of 78 nM, 16 nM and 86 nM for CLK1, CLK2 and CLK4, respectively). | |||
T13058 | T025 | CDK | |
T025 is a pan CLK inhibitor with Kds of 4.8, 0.096, 6.5, 0.61, and 0.074 nM for CLK1-4, respectively. T025 displays anti-proliferative activities with IC50s of 30-300 nM in hematological and solid cancer cell lines. T025... | |||
T1901 | (E/Z)-TG003 | TG003 | BCL , CDK |
(E/Z)-TG003 is a potent and ATP-competitive Cdc2-like kinase (Clk) inhibitor. | |||
T15657 | KH-CB19 | Others | |
KH-CB19 is an effective and highly specific inhibitor of the CDC2-like kinase isoforms 1 and 4 (CLK1/CLK4). | |||
T60367 | TG003 | ||
TG003, a potent inhibitor of Clk1/Sty, exhibits inhibitory activity against Clk1 and Clk4 with IC50 values of 20 nM and 15 nM, respectively [1]. | |||
T38757 | KH-CB20 | KH-CB20 | |
KH-CB20, an E/Z mixture, is a potent and selective inhibitor of CLK1 and CLK4 , with an IC 50 of 16.5 nM for CLK1 . KH-CB20 also can inhibits DYRK1A ( IC 50 =57.8 nM) and CLK3 ( IC 50 =488 nM). | |||
T60394 | Haspin-IN-2 | ||
Haspin-IN-2 (compound 4) is a potent, selective inhibitor of haspin, exhibiting an IC50 of 50 nM. Additionally, it inhibits CLK1 and DYRK1A, with IC50 values of 445 nM and 917 nM, respectively [1]. | |||
T61985 | EHT 5372 | ||
EHT 5372 is a potent and selective inhibitor of DYRK’s family kinases. EHT 5372 shows IC 50 s of 0.22, 0.28, 10.8, 93.2, 22.8, 88.8, 59.0, 7.44, 221 nM for DYRK1A, DYRK1B, DYRK2, DYRK3, CLK1, CLK2, CLK4, GSK-3α, GSK-3β. | |||
T79562 | Leucettinib-92 | CDK | |
Leucettinib-92 (compound 92) is a kinase inhibitor selective for DYRK/CLK families, displaying IC50 values of 147 nM (CLK1), 39 nM (CLK2), 5.2 nM (CLK4), 0.8 μM (CLK3), 124 nM (DYRK1A), 204 nM (DYRK1B), 0.16 μM (DYRK2), ... | |||
T21950 | K 00546 | ||
K00546, a potent inhibitor of both cyclin-dependent kinase (CDK1 and CDK2) and CDC2-like kinase (CLK1 and CLK3), demonstrates high specificity with IC50s of 0.6 nM and 0.5 nM for CDK1/cyclin B and CDK2/cyclin A, respecti... | |||
T2670 | ML167 | NCGC00188654,CID44968231 | DYRK , CDK |
ML167 (CID44968231) is a highly selective Cdc2-like kinase 4 (Clk4) inhibitor. | |||
T66481 | TG-693 | ||
TG693, an orally available inhibitor of CLK1, promotes the skipping of the endogenous mutated exon 31 in Duchenne muscular dystrophy (DMD) patient-derived cells and increased the production of the functional exon 31-skip... | |||
T60477 | Haspin-IN-1 | ||
Haspin-IN-1 (compound 2a) is an inhibitor of haspin (haploid germ cell-specific nuclear protein kinase) with an IC50 of 119 nM. Haspin-IN-1 also inhibits CLK1, DYRK1A, and CDK9 with IC50 of 221 nM, 916.3 nM, and 406.8 nM... | |||
T63101 | CJ-2360 | ||
CJ-2360 is a potent, orally active ALK inhibitor, capable of acting on wild-type ALK (IC50: 2.2 nM) and F1197M (IC50: 4.0 nM), G1269A (IC50: 8.8 nM), L1196M (IC50: 6.3 nM) and S1206Y ALK mutant (IC50: 8.9 nM). CJ-2360 st... | |||
T36684 | Ipivivint | ||
Ipivivint, a first-in-class, orally active and potent CDC-like kinase (CLK) inhibitor, inhibits CLK1 (IC50=1.4 μM), CLK2 (IC50=0.002 μM) and CLK3 (IC50=0.022 μM). Ipivivint reduces Wnt pathway signaling gene expression t... | |||
T38562 | AKN-028 | FLT | |
AKN-028 is an orally active and potent FLT3 tyrosine kinase inhibitor ( IC 50 = 6 nM). AKN-028 causes dose-dependent inhibition of FLT3 autophosphorylation. | |||
T14367 | AZ1495 | IRAK , CDK , Haspin Kinase | |
AZ1495 is an oral active inhibitor of Interleukin-1 receptor associated kinase 4 (IRAK4), with IC50 values of 5 nM and 23 nM for IRAK4 and IRAK1, respectively. Which Shows activity in treatment of mutant MYD88L265P diffu... | |||
T15204 | EHT 1610 | EHT 5372 | GSK-3 , NF-κB , Tyrosinase , DYRK , CDK |
EHT 1610 (EHT 5372) is a potent inhibitor of DYRK, with an IC50 of 0.36 nM and 0.59 nM for DYRK1A and DYRK1B, respectively. EHT 1610 has an inhibitory effect on leukemia, regulating cell cycle and inducing cell apoptosis... | |||
T12102 | Mps1-IN-1 | Others | |
Mps1-IN-1 is a potent, selective and ATP-competitive inhibitor of Mps1 kinase (IC50 : 367 nM ) |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01948 | COQ7 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Ubiquinone biosynthesis protein COQ7 homolog, also known as Coenzyme Q biosynthesis protein 7 homolog, Timing protein clk-1 homolog and COQ7, is a mitochondrion inner membrane and peripheral membrane protein which bel... | |||
TMPY-04404 | DCLK1 Protein, Human, Recombinant (aa 1-705, His & GST) | Human | Baculovirus Insect Cells |
DCLK1 Protein, Human, Recombinant (aa 1-705, His & GST) is expressed in Baculovirus insect cells with His and GST tag. The predicted molecular weight is 106 kDa and the accession number is O15075-1. | |||
TMPY-04752 | DCLK1 Protein, Human, Recombinant | Human | Baculovirus Insect Cells |
DCLK1 Protein, Human, Recombinant is expressed in Baculovirus insect cells. The predicted molecular weight is 78.5 kDa and the accession number is O15075-1. | |||
TMPY-04546 | CLK3 Protein, Human, Recombinant (GST) | Human | Baculovirus Insect Cells |
Dual specificity protein kinase CLK3, also known as CDC-like kinase 3, and CLK3, is a member of CMGC Ser/Thr protein kinase family and Lammer subfamily. Mammalian CLK is the prototype for a family of dual specificity ... |